doravirine
Key Takeaways for PrEP, HIV Treatment and Other Infectious Diseases
CROI 2025 highlighted promising therapeutic modalities for HIV treatment and prevention.
JULY 3, 2025
Delstrigo Demonstrates Long-Term HIV Suppression
Adults with HIV who were switched to the once-daily, fixed-dose Delstrigo combination tablet saw virologic ...
OCTOBER 5, 2018
FDA Approves Delstrigo and Pifeltro for HIV Treatment
The FDA approved Merck’s two doravirine-based HIV-1 medicines: Delstrigo, a once-daily fixed-dose combination ...
AUGUST 30, 2018
Investigational ART Efficacious, Well Tolerated
Doravirine (Merck), a late-stage investigational non-nucleoside reverse transcriptase inhibitor (NNRTI), was found ...
MARCH 9, 2018
Investigational ART Appears Safe and Effective
Dr. Carey Hwang discusses new research released at CROI 2018 about an investigational therapy being developed my ...
MARCH 7, 2018
